NASDAQ · BSEM
BioStem Technologies, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for BSEM: Nov 12, 2026
BioStem Technologies, Inc. Common Stock is estimated to report earnings on 11/12/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.43. The reported EPS for the same quarter last year was $0.03.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.43 | $-0.43 | $-0.43 | 1 |
| Dec 2026 | $-0.45 | $-0.45 | $-0.45 | 1 |
| Mar 2027 | $-0.38 | $-0.38 | $-0.38 | 1 |
| Jun 2027 | $-0.31 | $-0.31 | $-0.31 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Zacks · Quiver Quantitative- RTTNews · Sep 19, 1:01 AM EDTBioStem Secures Up To $40 Mln Committed Equity Facility(RTTNews) – BioStem Technologies (BSEM), a regenerative medicine company focused on perinatal tissue allograft products, has entered into a $40 million committed equity facility (CEF) with Roth Principal Investments, an affiliate of Roth Capital Partners.
- RTTNews · Sep 4, 7:12 AM EDTBioStem Technologies Expands Hospital Access For VENDAJE And VENDAJE AC Through Vizient And Premier(RTTNews) – BioStem Technologies, Inc. (BSEM), a regenerative medicine company focused on perinatal tissue allograft products, on Friday announced that VENDAJE and VENDAJE AC have been added to its existing contracts with Vizient, Inc. and Premier, Inc., two of the largest group
- RTTNews · Aug 20, 12:25 PM EDTBioStem Q2 Revenue Rises 29%; Raises 2026 Guidance, Uplists To Nasdaq(RTTNews) – BioStem Technologies, Inc. (BSEM), a regenerative medicine company focused on perinatal tissue allograft products, reported financial results for the second quarter ended June 30, 2026, highlighting 29% sequential revenue growth, raised full-year guidance and its rece
- Zacks · Aug 12, 5:40 PM EDTBioStem Technologies, Inc. (BSEM) Reports Q2 Loss, Beats Revenue EstimatesBioStem Technologies, Inc. (BSEM) delivered earnings and revenue surprises of -4.00% and +23.43%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Aug 11, 5:45 PM EDTCodexis (CDXS) Reports Q2 Loss, Tops Revenue EstimatesCodexis (CDXS) delivered earnings and revenue surprises of +23.53% and +17.20%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Aug 6, 9:50 AM EDTNovavax (NVAX) Reports Q2 Loss, Tops Revenue EstimatesNovavax (NVAX) delivered earnings and revenue surprises of +11.11% and +13.31%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Aug 5, 6:10 PM EDTCytek Biosciences, Inc. (CTKB) Reports Q2 Loss, Tops Revenue EstimatesCytek Biosciences (CTKB) delivered earnings and revenue surprises of -150.00% and +1.66%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · May 14, 5:50 PM EDTBioStem Technologies, Inc. (BSEM) Reports Q1 Loss, Tops Revenue EstimatesBioStem Technologies, Inc. (BSEM) delivered earnings and revenue surprises of -85.71% and +7.64%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · May 13, 5:35 PM EDTPrecigen, Inc. (PGEN) Reports Q1 Loss, Tops Revenue EstimatesPrecigen (PGEN) delivered earnings and revenue surprises of +20.00% and +9.99%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- Quiver Quantitative · May 12, 4:55 PM EDT$BSEM Earnings Results: $BSEM Reports Quarterly Earnings$BSEM ($BSEM) posted quarterly earnings results on Monday, May 12th. The company reported earnings of $0.17 per share, missing estimates of $1.27 by $1.10. The company also reported revenue of $72,530,000, missing estimates of $103,122,000 by $-30,592,000.
- Quiver Quantitative · Apr 5, 5:05 PM EDT$BSEM Earnings Preview: Recent $BSEM Insider Trading, Hedge Fund Activity, and More$BSEM ($BSEM) is expected to release its quarterly earnings data on Monday, April 7th after market close, per Finnhub. Analysts are expecting revenue of $88,418,700 and earnings of $0.38 per share.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for BioStem Technologies, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.